Sodium arsenate induces overproduction of interleukin-1α in murine keratinocytes: Role of mitochondria

Journal of Investigative Dermatology

Volumn 113, Issue 5, 1999, Pages 760-765

  Corsini, Emanuela ^a   Asti, Lia ^a   Viviani, Barbara ^a   Marinovich, Marina ^a   Galli, Corrado L ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cytokines; Hyperkeratosis; Reactive oxygen species; Skin tumor

Indexed keywords

ARSENATE SODIUM; ETHIDIUM BROMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1ALPHA; KERATINOCYTE GROWTH FACTOR; MITOCHONDRIAL DNA; MITOCHONDRIAL RNA; REACTIVE OXYGEN METABOLITE; ROTENONE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SYNTHESIS; HYPERKERATOSIS; KERATINOCYTE; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RNA SYNTHESIS; SKIN CANCER;

EID: 0032734525     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00748.x     Document Type: Article

References (29)

1. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179, 1994
2. Brown MM, Rhyne BC, Goyer RA, Fowler BA: Intracellular effects of chronic arsenic administration on renal proximal tubule cells. J Toxicol Environ Health 1:505-514, 1976
3. Brown KG, Guo HR, Kuo TL, Greene HL: Skin cancer and inorganic arsenic: uncertainty-status of risk. Risk Anal 17:37-42, 1997
4. Cadenas E, Boveris A, Ragan CI, Stoppani AO: Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinolcytochrome reductase from beef-heart mitochondria. Arch Biochem Biophys 180:248-257, 1977
5. Chacon E, Acosta D: Mitochondrial regulation of superoxide by Ca2+: an altered mechanism for the cardiotoxicity of doxorubicin. Toxic Appl Pharmacol 107:117-128, 1991
6. Coetzee WA, McLoughlin JL, Opie LH: The damaging effects of superoxide oxygen radicals in guinea pig ventricular myocytes are mediated by calcium. J Mol Cell Cardiol 21:S41, 1989
7. Corsini E, Marinovich M, Marabini L, Chiesara E, Galli CL: (1994). Inteleukin-1 production after treatment with non-ionic surfactants in a murine keratinocyte cell line. Toxicol Vitro 8:361-369, 1994
8. Corsini E, Bruccoleri A, Marinovich M, Galli CL: Endogenous interieukin-1α is associated with skin irritation induced by tributyltin. Toxicol Appl Pharmacol 138:268-274, 1996a
9. Corsini E, Schubert C, Marinovich M, Galli CL: Role of mitochondria in triburyltin-induced interleukin-1α production in murine keratinocytes. J Invest Dermatol 107:720-725, 1996b
10. Fenton MJ: Review: transcriptional and post-transcriptional regulation of interleukin 1 gene expression. Int J Immunopharmacol 14:401-411, 1992
11. Germolec DR, Yoshida T, Gaido K, et al: Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol Appl Pharmacol 141:308-318, 1996
12. Germolec DR, Spalding J, Boorman GA, et al: Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mut Res 386:209-218, 1997
13. Gniadecki R: Regulation of keratinocyte proliferation. Gen Phamarcol 30:619-622, 1998
14. Groves RW, Mizutani H, Kieffer JD, Kupper TS: Inflammatory skin disease in transgenic mice that express high levels of interleukin-1α in basal epidermis. Proc Natl Acad, Sci USA 92:11874-11878, 1995
15. Groves RW, Rauschmayer T, Nakamura K, Sarkar S, Williams IR, Kupper TS: Inflammatory and hyperproliferative skin disease in mice that express elevated level of IL-1 receptor on epidermal keratinocytes. Evidence that IL-1 inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease. J Clin Invest 98:336-344, 1996
16. Ilnicka M, Lee SW, Eugui EM: Antioxidants inhibit activation of transcription factors and cytokine gene transcription in monocytes. Ann NY Acad Sci 696:396-398, 1993
17. King MP, Attardi G: Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246:500-503, 1989
18. Lee SW, Ilnicka M: Hydrogen peroxide primes promonocytic U937 cells to produce IL-1β Ann NY Acad Sci 696:399-401, 1993
19. Lee SW, Morhenn VB, Ilnicka M, Eugui EM, Allison AC: Aurocrine stimulation of interleukin-1 alpha and transforming growth factor alpha production in human keratinocytes and its antagonism by glucocorticoids. J Invest Dematol 97:106-110, 1991
20. 74As-arsenite or -arsenate. Acta Pharmacol Toxicol 51:253-265, 1982
21. Maas-Szabowski N, Fusening NE: IL-1-induced growth factor expression in postmitotic and resting fibroblasts. J Invest Dermatol 107:849-855, 1996
22. Maloney ME: Arsenic in dermatology. Dematol Surg 22:301-304, 1996
23. Mitchell RA, Change BF, Huang CH, DeMaster EG: Inhibition of mitochondrial energy-linked functions by arsenate. Biochemistry 10:2049-2054, 1971
24. Muegge K, Durum SK: Cytokines and transcription factors. Cytokine 2:1-8, 1990
25. Schreck Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10:2247-2250, 1991
26. Schreiber EP, Matthias MM, Schaffner W: Rapid detection of octameric binding proteins with 'mini-extract' prepared from a small number of cells. Nucleic Acids Res 17:6419, 1989
27. Vahter M, Envall J: In vivo reduction of arsenate in mice and rabbits. Environ Res 32:14-24, 1983
28. World Health Organization: Environmental Health Criteria 18 - Arsenic. International Programme on Chemical Safety, Geneva, 1981
29. Yamauchi H, Yamamura Y: Dynamic change of inorganic arsenic and methylarsenic compounds in human urine after oral intake as arsenic trioxide. Ind Health 17:79-83, 1979